One-Year Follow-Up of Stage IB1 Cervical Cancer After Radical Hysterectomy

One-Year Follow-Up of Stage IB1

Authors

  • Andika Adi Saputra Achmad Abdoel Wahab Sjahranie Samarinda Hospital, Samarinda, East Kalimantan, Indonesia
  • Andi Hafiz Rajendra Faculty of Medicine, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia

DOI:

https://doi.org/10.59747/4x618z65

Keywords:

Cervical cancer; Sedlis criteria; recurrence; radical hysterectomy

Abstract

Background: Cervical cancer is the third most common cancer among women worldwide and is entirely caused by infection with the Human Papillomavirus (HPV). HPV types 16 and 18 are the types most frequently found in invasive cervical cancer. Population-based HPV prevalence studies show that the highest incidence occurs in women under 25 years of age, and mortality from cervical cancer peaks among middle-aged women between 40 and 50 years old.  

Objective: The objective of this case report is to describe the one-year follow-up outcomes of stage IB1 cervical cancer after radical hysterectomy.  

Cases: We report two cases involving 46- and 47-year-old women diagnosed with stage IB1 cervical cancer. Radical hysterectomy was performed in both patients, and adjuvant radiotherapy was administered to one patient based on the Sedlis criteria. Both patients returned for follow-up one year after surgery, and no recurrence or persistence of cervical cancer was found.  

Conclusions: Cervical cancer is a disease whose prognosis is highly influenced by its stage of development. Routine screening is the main modality to improve the prognosis of cervical cancer. In early stages, surgical management is effective as the primary treatment for cervical cancer, particularly to avoid the long-term side effects frequently associated with radiation therapy. Regular postoperative evaluation is essential to detect recurrence as early as possible and give patients the best chance of optimal disease management.

References

Abu-Rustum, N. R., Yashar, C. M., Bean, S., Bradley, K., Campos, S. M., Chon, H. S., Chu, C., Cohn, D., Crispens, M. A., Damast, S., Fisher, C. M., Frederick, P., Gaffney, D. K., Giuntoli, R., Han, E., Huh, W. K., Lurain Iii, J. R., Mariani, A., Mutch, D., … Motter, A. D. (2020). NCCN guidelines insights: Cervical cancer, version 1. 2020: featured updates to the nccn guidelines. Journal of the National Comprehensive Cancer Network, 18(6), 660–666. https://doi.org/10.6004/jnccn.2020.0027

Bae, B. K., Cho, W. K., Kim, B.-G., Choi, C. H., Kim, T.-J., Lee, Y.-Y., Lee, J.-W., & Park, W. (2022). Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: Implications on risk group stratification. International Journal of Gynecological Cancer, 32(12), 1524–1530. https://doi.org/10.1136/ijgc-2022-003971

Berek, J. S., & Hacker, N. (2015). Berek & Hacker’s Gynecologic Oncology, 6e. Lippincott Williams & Wilkins.

Bogani, G., Di Donato, V., Scambia, G., Raspagliesi, F., Chiantera, V., Sozzi, G., Golia D’Augè, T., Muzii, L., Benedetti Panici, P., D’Oria, O., Vizza, E., & Giannini, A. (2022). Radical hysterectomy for early stage cervical cancer. International Journal of Environmental Research and Public Health, 19(18), 11641. https://doi.org/10.3390/ijerph191811641

Burmeister, C. A., Khan, S. F., Schäfer, G., Mbatani, N., Adams, T., Moodley, J., & Prince, S. (2022). Cervical cancer therapies: Current challenges and future perspectives. Tumour Virus Research, 13, 200238. https://doi.org/10.1016/j.tvr.2022.200238

Cao, L., Wen, H., Feng, Z., Han, X., Zhu, J., & Wu, X. (2021). Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer. International Journal of Gynecological Cancer, 31(1), 52–58. https://doi.org/10.1136/ijgc-2020-001974

Caruso, G., Gaiano, M., De Vitis, L. A., Stefani, E., Rosanu, M., Ribero, L., Alessi, S., Petralia, G., Casarin, J., Gandini, S., Maggioni, A., Aletti, G. D., Zanagnolo, V., Colombo, N., Schivardi, G., & Multinu, F. (2025). Predictors of recurrence in early-stage cervical cancer without adjuvant treatment after radical surgery. European Journal of Surgical Oncology, 51(8), 110121. https://doi.org/10.1016/j.ejso.2025.110121

Chen, Y., Zhu, Y., & Wu, J. (2021). Prognosis of early stage cervical cancer according to patterns of recurrence. Cancer Management and Research, 13, 8131–8136. https://doi.org/10.2147/CMAR.S314384

Chu, R., Zhang, Y., Qiao, X., Xie, L., Chen, W., Zhao, Y., Xu, Y., Yuan, Z., Liu, X., Yin, A., Wang, Z., Zhang, Q., Yang, X., Su, X., Kong, B., & Song, K. (2021). Risk stratification of early‐stage cervical cancer with intermediate‐risk factors: Model development and validation based on machine learning algorithm. The Oncologist, 26(12), e2217–e2226. https://doi.org/10.1002/onco.13956

Elit, L., Fyles, A. W., Oliver, T. K., Devries–Aboud, M. C., Fung-Kee-Fung, M., & members of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. (2010). Follow-Up for Women after Treatment for Cervical Cancer. Current Oncology, 17(3), 65–69. https://doi.org/10.3747/co.v17i3.514

Elliott, S. P., & Malaeb, B. S. (2011). Long-term urinary adverse effects of pelvic radiotherapy. World Journal of Urology, 29(1), 35–41. https://doi.org/10.1007/s00345-010-0603-x

Fowler, J. R., Maani, E. V., Dunton, C. J., Gasalberti, D. P., & Jack, B. W. (2025). Cervical cancer. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK431093/

Haesen, J., Salihi, R., Van Gorp, T., Van Nieuwenhuysen, E., Han, S. N., Christiaens, M., Van Rompuy, A.-S., Waumans, L., Neven, P., & Vergote, I. (2021). Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria. Gynecologic Oncology, 162(3), 539–545. https://doi.org/10.1016/j.ygyno.2021.06.026

Miccò, M., Lupinelli, M., Mangialardi, M., Gui, B., & Manfredi, R. (2022). Patterns of Recurrent Disease in Cervical Cancer. Journal of Personalized Medicine, 12(5). https://doi.org/10.3390/jpm12050755

Morris, K. A., & Haboubi, N. Y. (2015). Pelvic radiation therapy: Between delight and disaster. World Journal of Gastrointestinal Surgery, 7(11), 279–288. https://doi.org/10.4240/wjgs.v7.i11.279

Saia, P. J. D., Creasman, W. T., Mannel, R. S., McMeekin, D. S., & Mutch, D. G. (2018). Clinical Gynecologic Oncology. Elsevier Inc.

Sedlis, A., Bundy, B. N., Rotman, M. Z., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (1999). A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecologic Oncology, 73(2), 177–183. https://doi.org/10.1006/gyno.1999.5387

Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020). Cervical cancer: Epidemiology, risk factors and screening. Chinese Journal of Cancer Research, 32(6), 720–728. https://doi.org/10.21147/j.issn.1000-9604.2020.06.05

Downloads

Published

2026-11-19

Issue

Section

Case report/Case series/Image article

Categories